Methods of treating migraine comprising conformationally constrained compounds which mimic the secondary structure of reverse-turn regions of biologically active peptides are disclosed. The compounds of the present invention of Formula I have valuable pharmacological properties based on their ability to selectively antagonize calcitonin gene-related peptide (CGRP) receptor for acute and prophylactic treatment of headaches, particularly migraines.
本发明涉及一种治疗偏头痛的方法,其中使用构象受限化合物,其模拟
生物活性肽的反转区域的二级结构。根据本发明的化合物具有的公式I,这些化合物具有有价值的药理特性,能够通过选择性拮抗
钙调素
基因相关肽(CGRP)受体,用于急性和预防性治疗头痛,特别是偏头痛。